ReviewMetabolic brain disease2025

Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer's disease in type 2 diabetes.

Prakash Ramakrishan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.